Attached files

file filename
8-K - FORM 8-K - RCM TECHNOLOGIES, INC.rcmt20210810_8k.htm

Exhibit 99

 rcm01.jpg

RCM Technologies, Inc.

Tel: 856.356.4500

Corporate Contacts:

2500 McClellan Avenue

Fax: 856.356.4600

Bradley S. Vizi

Pennsauken, NJ 08109

info@rcmt.com

Executive Chairman

 

www.rcmt.com

Kevin D. Miller

   

Chief Financial Officer

 

 

P R E S S   R E L E A S E

 

RCM TECHNOLOGIES, INC. ANNOUNCES

SECOND QUARTER RESULTS

 

Pennsauken, NJ – August 12, 2021 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care and information technology services, today announced financial results for the thirteen and twenty-six week periods ended July 3, 2021.

 

RCM Technologies reported revenue of $48.9 million for the thirteen week period ended July 3, 2021 (the current period), a 49.9% increase as compared to $32.7 million for the thirteen week period ended June 27, 2020 (the comparable prior year period). Gross profit was $12.3 million for the current period, a 44.3% increase as compared to $8.5 million for the comparable prior year period.  The Company experienced GAAP operating income of $1.9 million for the current period, as compared to a GAAP operating loss of $1.2 million for the comparable prior year period.  The Company experienced GAAP net income of $1.3 million, or $0.11 per diluted share, for the current period as compared to a GAAP net loss of $1.0 million, or ($0.08) per diluted share, for the comparable prior year period.

 

RCM Technologies reported revenue of $93.5 million for the twenty-six week period ended July 3, 2021 (the current period), a 20.3% increase as compared to $77.7 million for the twenty-six week period ended June 27, 2020 (the comparable prior year period). Gross profit was $23.1 million for the current period, a 19.5% increase as compared to $19.3 million for the comparable prior year period.  The Company experienced GAAP operating income of $3.3 million for the current period, as compared to a GAAP operating loss of $8.9 million for the comparable prior year period.  The Company experienced GAAP net income of $2.3 million, or $0.19 per diluted share, for the current period as compared to a GAAP net loss of $6.9 million, or ($0.54) per diluted share, for the comparable prior year period.

 

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “Our second-quarter results continued the strong momentum we established as we exited 2020 and entered 2021. Across each division, revenue, profitability, and overall business activity increased sequentially, and many measures showed meaningful improvement in year-over-year performance.”

 

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “The generation of $15.3 million in cash flow from operations and strong EBITDA in the second quarter allows us to continue to make measured investments in our segments, all of which we believe are serving attractive end markets. We believe our momentum will continue into the second half of fiscal 2021 and have now shifted our focus to continuing this growth trajectory going forward from there.”

 

 

 

 

Conference Call

On Friday, August 13, 2021, RCM Technologies will host a conference call to discuss these results. The call will begin at 11:00 a.m. Eastern Time. The dial-in number is (866) 578-1005.

 

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in the delivery of these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM’s offices are located in major metropolitan centers throughout North America and Serbia. Additional information can be found at www.rcmt.com.

 

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to the impact of the COVID-19 pandemic, demand for the Company’s services, expectations regarding our future revenues and other financial results, our pipeline and potential project wins and our expectations for growth in our business. Such statements are based on current expectations that involve a number of known and unknown risks, uncertainties and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

 

Tables to Follow

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

 

Thirteen Week Periods Ended

 
 

July 3, 2021

 

June 27, 2020

 

Revenue

$48,933

 

$32,652

 

Cost of services

36,667

 

24,149

 

Gross profit

12,266

 

8,503

 

Selling, general and administrative

9,995

 

8,994

 

Depreciation and amortization of property and equipment

259

 

246

 

Amortization of acquired intangible assets

9

 

80

 

Write-off of receivables and professional fees incurred related to arbitration

-

 

350

 

Tax credit professional fees

60

 

-

 

Operating income (loss)

1,943

 

(1,167

)

Other expense, net

201

 

233

 

Income (loss) before income taxes

1,742

 

(1,400

)

Income tax expense (benefit)

486

 

(408

)

Net income (loss)

$1,256

 

($992

)

         

Diluted net earnings (loss) per share data

$0.11

 

($0.08

)

 

 

Twenty-Six Week Periods Ended

 
 

July 3, 2021

 

June 27, 2020

 

Revenue

$93,482

 

$77,685

 

Cost of services

70,366

 

58,339

 

Gross profit

23,116

 

19,346

 

Selling, general and administrative

19,064

 

19,231

 

Depreciation and amortization of property and equipment

525

 

501

 

Amortization of acquired intangible assets

89

 

160

 

Write-off of receivables and professional fees incurred related to arbitration

-

 

8,397

 

Tax credit professional fees

120

 

-

 

Operating income (loss)

3,318

 

(8,943

)

Other expense, net

213

 

642

 

Income (loss) before income taxes

3,105

 

(9,585

)

Income tax expense (benefit)

842

 

(2,648

)

Net income (loss)

$2,263

 

($6,937

)

         

Diluted net earnings (loss) per share data

$0.19

 

($0.54

)

 

RCM Technologies, Inc.

Summary Consolidated Selected Balance Sheet Data

(In Thousands)

 

July 3,

2021

 

January 2,

2021

 

(Unaudited)

   

Cash and cash equivalents

$1,399

 

$734

Accounts receivable, net

$37,323

 

$36,007

Total current assets

$41,886

 

$43,934

Total assets

$64,697

 

$68,339

Total current liabilities

$29,233

 

$28,741

Borrowing under line of credit

$9,686

 

$11,890

Net debt (line of credit less cash)

$8,287

 

$11,156

Total liabilities

$41,832

 

$46,101

Stockholders’ equity

$22,865

 

$22,238

 

 

 

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands)

 

The following non-GAAP measures, which adjust for the categories of expenses described below, primarily changes in contingent consideration as a result of re-measurement in the amount of contingent consideration we expect to pay with respect to past acquisitions, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures (“EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders and other stakeholders of our company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons. We believe that both EBITDA and Adjusted EBITDA are performance measures and not liquidity measures, and therefore a reconciliation between net income and EBITDA and Adjusted EBITDA has been provided. Neither EBITDA nor Adjusted EBITDA should be considered as an alternative to net income as an indicator of performance. In addition, neither EBITDA nor Adjusted EBITDA takes into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

The following unaudited table presents the Company's GAAP Net Income measure and the corresponding adjustments used to calculate “EBITDA” and “Adjusted EBITDA” for the thirteen and twenty-six week periods ended July 3, 2021 and June 27, 2020.

 

 

Thirteen Week

Periods Ended

 

Twenty-Six Week

Periods Ended

 
 

July 3,

2021

 

June 27,

2020

 

July 3,

2021

 

June 27,

2020

 

GAAP net income (loss)

$1,256

 

($992

)

$2,263

 

($6,937

)

Income tax expense (benefit)

486

 

(408

)

842

 

(2,648

)

Interest expense

122

 

184

 

243

 

524

 

Change in fair value of contingent consideration

26

 

36

 

52

 

72

 

Depreciation of property and equipment

259

 

246

 

525

 

501

 

Amortization of acquired intangible assets

9

 

80

 

89

 

160

 

EBITDA (non-GAAP)

$2,158

 

($854

)

$4,014

 

($8,328

)

                 

Adjustments

               

   Write-off of receivables and professional fees

    incurred related to arbitration

-

 

350

 

-

 

8,397

 

   Tax credit professional fees

60

 

-

 

120

 

-

 

   Loss (gain) on foreign currency transactions

53

 

13

 

(82

)

46

 

Adjusted EBITDA (non-GAAP)

$2,271

 

($491

)

$4,052

 

$115

 

 

 

 

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

 

 

Thirteen Week Periods Ended

 
 

July 3,

2021

 

June 27,

2020

 

Net income (loss)

$1,256

 

($992

)

Adjustments to reconcile net income to cash

   used in operating activities

1,063

 

(38

)

Changes in operating assets and liabilities:

       
 

Accounts receivable

8,156

 

11,253

 
 

Prepaid expenses and other current assets

1,375

 

1,620

 
 

Net of transit accounts receivable and payable

1,679

 

(66

)

 

Accounts payable and accrued expenses

2,494

 

2,745

 
 

Accrued payroll and related costs

(399

)

2,239

 
 

Right of use assets

266

 

304

 
 

Right of use liabilities

(491

)

(284

)

 

Income taxes payable

(92

)

110

 

Total adjustments

14,051

 

17,846

 

Net cash provided by operating activities

$15,307

 

$16,854

 
         

Net cash used in investing activities

(89

)

(76

)

Net cash provided by (used in) financing activities

(14,529

)

(15,830

)

Effect of exchange rate changes

32

 

42

 

Decrease in cash and cash equivalents

$721

 

$990

 

 

 

 

Twenty-Six Week Periods Ended

 
 

July 3,

2021

 

June 27,

2020

 

Net income (loss)

$2,263

 

($6,937

)

Adjustments to reconcile net income to cash

   used in operating activities

1,949

 

5,977

 

Changes in operating assets and liabilities:

       
 

Accounts receivable

(929

)

12,227

 
 

Prepaid expenses and other current assets

1,957

 

1,786

 
 

Net of transit accounts receivable and payable

(123

)

907

 
 

Accounts payable and accrued expenses

1,906

 

2,739

 
 

Accrued payroll and related costs

(212

)

950

 
 

Right of use assets

412

 

1,166

 
 

Right of use liabilities

(857

)

(1,163

)

 

Income taxes payable

(249

)

131

 

Total adjustments

3,854

 

24,720

 

Net cash provided by operating activities

$6,117

 

$17,783

 
         

Net cash used in investing activities

(136

)

(111

)

Net cash used in financing activities

(5,214

)

(17,764

)

Effect of exchange rate changes

(102

)

(123

)

Increase (decrease) in cash and cash equivalents

$665

 

($215

)

 

 

 

 

RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

 

 

 

Thirteen Week Period Ended July 3, 2021

 
 

Engineering

 

Specialty

Health Care

 

Information

Technology

 

Consolidated

 
                 

Revenue

$16,934

 

$22,941

 

$9,058

 

$48,933

 

Cost of services

12,920

 

17,349

 

6,398

 

36,677

 

Gross profit

$4,014

 

$5,592

 

$2,660

 

$12,266

 

Gross profit margin

23.7

%

24.4

%

29.4

%

25.1

%

 

 

 

 

Thirteen Week Period Ended June 27, 2020

 
 

Engineering

 

Specialty

Health Care

 

Information

Technology

 

Consolidated

 
                 

Revenue

$14,038

 

$10,684

 

$7,930

 

$32,652

 

Cost of services

9,804

 

8,487

 

5,858

 

24,149

 

Gross profit

$4,234

 

$2,197

 

$2,072

 

$8,503

 

Gross profit margin

30.2

%

20.6

%

26.1

%

26.0

%

 

 

 

 

Twenty-Six Week Period Ended July 3, 2021

 
 

Engineering

 

Specialty

Health Care

 

Information

Technology

 

Consolidated

 
                 

Revenue

$31,400

 

$44,077

 

$18,005

 

$93,482

 

Cost of services

24,180

 

33,448

 

12,738

 

70,366

 

Gross profit

$7,220

 

$10,629

 

$5,267

 

$23,116

 

Gross profit margin

23.0

%

24.1

%

29.3

%

24.7

%

 

 

 

 

Twenty-Six Week Period Ended June 27, 2020

 
 

Engineering

 

Specialty

Health Care

 

Information

Technology

 

Consolidated

 
                 

Revenue

$28,201

 

$32,881

 

$16,603

 

$77,685

 

Cost of services

20,001

 

26,311

 

12,027

 

58,339

 

Gross profit

$8,200

 

$6,570

 

$4,576

 

$19,346

 

Gross profit margin

29.1

%

20.0

%

27.6

%

24.9

%